Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Inclusion Criteria:

• subjects over 18 years,
• subject about having a chest pain of coronary syndrome,
• subject about not having received heparin or LMWH

Exclusion Criteria:

• subject minor
• subject without informed consent,
• subject after receiving an anticoagulant treatment,
• transplanted heart, kidney or liver